Reciprocally, our results demonstrated that p300 promoted FLT3 transcription through histone acetylation and inhibition of p300/CBP suppressed FLT3 expression and downstream pathways, leading to selective efficacy in FLT3-ITD AML. This evidence concerns the gene EP300 and acute myeloid leukemia.